<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-2013-27-7-10</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-27-7-10</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Sleep Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Thalamic Glutamate/Glutamine in Restless Legs Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Ann &#x0026; Robert H. Lurie Children&#x0027;s Hospital of Chicago, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1">
<label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>07</month>
<year>2013</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>15</day>
<month>10</month>
<year>2015</year>
</pub-date>
<volume>27</volume>
<issue>7</issue>
<fpage>55</fpage>
<lpage>56</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2013 The Author(s)</copyright-statement>
<copyright-year>2013</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1212/WNL.0b013e318294b3f6" vol="80" page="2028">
<article-title>Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Investigators at Johns Hopkins University, Baltimore, MD, studied glutaminergic activity and arousal in 28 adults with restless legs syndrome (RLS) and 20 matched controls, using proton magnetic resonance spectroscopy.</p>
</abstract>
<kwd-group>
<kwd>Restless Legs Syndrome</kwd>
<kwd>Glutamate Metabolism</kwd>
<kwd>Oral Iron Treatment</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Investigators at Johns Hopkins University, Baltimore, MD, studied glutaminergic activity and arousal in 28 adults with restless legs syndrome (RLS) and 20 matched controls, using proton magnetic resonance spectroscopy. The thalamic glutamate/glutamine/creatine ratio was higher in patients with RLS than controls (p=0.016) and correlated significantly with the wake time during the sleep period (p=0.007) and all other RLS-related polysomnographic sleep variables (p&#x003C;0.05) except for periodic leg movements during sleep (PLMS/hour). Glutamate metabolism is strongly related to arousal sleep disturbance but not to PLMS motor features of RLS. This finding contrasts with the reverse for dopamine that shows a limited relation to arousal sleep disturbance but strong relation to PLMS. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENT. An increased glutaminergic activity in RLS demonstrated in this study represents a new RLS abnormality involving thalamocortical activation in a major nondopaminergic neurologic system. The authors (Allen RP, et al) conclude that the combination of glutaminergic (sleep disturbance) and dopaminergic (sensory symptoms, PLMS) abnormalities are involved in the full RLS symptomatology. The elevated glutamate levels are considered a reflection of &#x201C;hyperarousal&#x201D; of RLS, which leads to sleep disturbance at night.</p>
<p>In an editorial [<xref ref-type="bibr" rid="CIT0002">2</xref>], Winkelman JW asks the question, is RLS a sleep disorder, a movement disorder, or a chronic pain disorder? He concludes that individual patients should be subtyped into biologically based phenotypes, with or without sleep disturbance, PLMS, or painful RLS. Although the current Hopkins study was confined to older subjects, RLS is also a pediatric problem and is closely associated with brain iron insufficiency and dopaminergic dysfunction. [<xref ref-type="bibr" rid="CIT0003">3</xref>, <xref ref-type="bibr" rid="CIT0004">4</xref>]</p>
<p><bold>Oral iron and RLS.</bold> Oral iron treatment is initiated for RLS if serum ferritin is below 50 ng/mL. In a study of 22 children referred because of sleep disturbances, median age at onset of RLS symptoms was 7.5 months (range, 0-40 months). In addition to kicking or hitting the legs, the most striking symptoms were awakening after 1-3 hours of sleep followed by screaming and crying. Oral iron supplementation had a positive ferritin-concentration-dependent clinical effect. A relation between high PLMS index and low ferritin levels was demonstrated. An increased awareness of RLS in early childhood is recommended. [<xref ref-type="bibr" rid="CIT0005">5</xref>]</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Barker</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Horsk&#x00E1;</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Earley</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep</article-title>
<source>Neurology</source>
<year>2013</year>
<month>May</month>
<day>28</day>
<volume>80</volume>
<issue>22</issue>
<fpage>2028</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e318294b3f6</pub-id>
<pub-id pub-id-type="pmid">23624560</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winkelman</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Is restless legs syndrome a sleep disorder?</article-title>
<source>Neurology</source>
<year>2013</year>
<month>May</month>
<day>28</day>
<volume>80</volume>
<issue>22</issue>
<fpage>2006</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e318294b4bb</pub-id>
<pub-id pub-id-type="pmid">23624567</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Connor</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Ponnuru</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>XS</given-names>
</name>
<name>
<surname>Patton</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Earley</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>Profile of altered brain iron acquisition in restless legs syndrome</article-title>
<source>Brain</source>
<year>2011</year>
<month>Apr</month>
<volume>134</volume>
<issue>Pt 4</issue>
<fpage>959</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awr012</pub-id>
<pub-id pub-id-type="pmid">21398376</pub-id>
</element-citation>
</ref>
<ref id="CIT0004">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dosman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Witmans</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zwaigenbaum</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Iron&#x2019;s role in paediatric restless legs syndrome - a review</article-title>
<source>Paediatr Child Health</source>
<year>2012</year>
<month>Apr</month>
<volume>17</volume>
<issue>4</issue>
<fpage>193</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">23543250</pub-id>
</element-citation>
</ref>
<ref id="CIT0005">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilma</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tilma</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Norregaard</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Ostergaard</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Early childhood-onset restless legs syndrome: symptoms and effect of oral iron treatment</article-title>
<source>Acta Paediatr</source>
<year>2013</year>
<month>May</month>
<volume>102</volume>
<issue>5</issue>
<fpage>e221</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1111/apa.12173</pub-id>
<pub-id pub-id-type="pmid">23360128</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
